Neurocognitive changes in cancer survivors

Area of Science:

• Oncology
• Neuroscience
• Pharmacology

Background:

• Cognitive adverse effects are a concern for breast cancer patients undergoing chemotherapy.
• Previous studies reported variable prevalence of chemotherapy-related cognitive dysfunction.
• Recent literature shows a need for further investigation into underlying mechanisms.

Purpose of the Study:

• To review recent literature on cognitive adverse effects of chemotherapy in breast cancer patients.
• To summarize findings on the prevalence and characteristics of chemotherapy-induced cognitive dysfunction.
• To highlight current research directions, including neuroimaging and animal models.

Main Methods:

• Literature review of recent studies on chemotherapy's cognitive effects in breast cancer.
• Analysis of cross-sectional and prospective study designs.
• Inclusion of studies utilizing neuroimaging and animal models.

Main Results:

• Prevalence of cognitive dysfunction varied across studies, particularly in cross-sectional designs.
• Prospective studies identified cognitive difficulties in subgroups, mainly short-term.
• Some studies found no evidence of cognitive impairment.
• Neuroimaging and animal models are beginning to explore structural and functional correlates.

Conclusions:

• Significant progress has been made in understanding chemotherapy-related cognitive dysfunction.
• Further research is needed to elucidate the mechanisms of treatment-related toxicity.
• A multidisciplinary approach is crucial for advancing this field.